Esteve and Leitat, CataloniaBio & HealthTech members, have signed a strategic alliance to create a business incubator specialising in biomedicine, that will be headquartered in the facilities that were occupied until now by Esteve in the Barcelona Science Park.

WeLab, as the incubator has been called, will allow Esteve to continue developing its R&D portfolio and have preferential access to the most advanced innovation and technologies in the biomedical field through the Leitat network.

For Joan Parra, executive vice-president of Leitat, ''WeLab will allow to create a new international player in future's medicines research in a moment where everybody understands how important this activity is''.

Staffan Schüberg, CEO of Esteve said, ''WeLab is a new step forward in our strategic journey of becoming a global innovative specialty pharmaceutical company''.

According to the Catalan Minister Àngels Chacón, ''the enforcement of the Catalan system of technology transfer is a priority and, without any doubt, agreements like this one contribute substantially''.

More information

Photo: From left to right, Staffan Schüberg and Joan Parra - © Esteve

Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Remedi is born from the fusion of the co...

by Regenera Activa Worldwide

Regenera Activa Worldwide and Rigenera HBW, biotech firms specializing...

Photos Stream